Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
57.1M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
57.6M
-
Shares change
-
-824K
-
Total reported value, excl. options
-
$310M
-
Value change
-
-$4.21M
-
Put/Call ratio
-
0
-
Number of buys
-
57
-
Number of sells
-
-54
-
Price
-
$5.36
Significant Holders of Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS) as of Q2 2025
133 filings reported holding ATXS - Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share as of Q2 2025.
Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.6M shares
.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (6.49M shares), FMR LLC (6.46M shares), Vestal Point Capital, LP (4.52M shares), FCPM III SERVICES B.V. (4.11M shares), BlackRock, Inc. (3.7M shares), Fairmount Funds Management LLC (3.55M shares), MILLENNIUM MANAGEMENT LLC (2.97M shares), TCG Crossover Management, LLC (2.76M shares), VANGUARD GROUP INC (2.52M shares), and VR ADVISER, LLC (2.46M shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.